{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:51:17Z","timestamp":1761897077224},"reference-count":149,"publisher":"Georg Thieme Verlag KG","issue":"07","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Horm Metab Res"],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Since Felix Fr\u00e4nkel\u2019s account of pheochromocytoma in 1886, great discoveries and vast advancements in the diagnosis, genetics, anatomical and functional imaging techniques, and surgical management of pheochromcytoma and paraganglioma (P-PGL) have been made. The improved insight in the pathophysiology of P-PGL and more accurate detection methods enable physicians to tailor the treatment plan to an individual based on the genetic profile and tumor behavior. This review will cover briefly the clinical features, diagnosis, genetic mutations, and imaging modalities that are used to guide current surgical management of these rare and interesting endocrinopathies.<\/jats:p>","DOI":"10.1055\/a-0926-3618","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T22:41:08Z","timestamp":1563230468000},"page":"470-482","source":"Crossref","is-referenced-by-count":10,"title":["Precision Surgery for Pheochromocytomas and Paragangliomas"],"prefix":"10.1055","volume":"51","author":[{"given":"Douglas","family":"Wiseman","sequence":"additional","affiliation":[{"name":"Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustapha El","family":"Lakis","sequence":"additional","affiliation":[{"name":"Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naris","family":"Nilubol","sequence":"additional","affiliation":[{"name":"Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/MPA.0b013e3181ebb4f0","article-title":"The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: Pheochromocytoma, paraganglioma, and medullary thyroid cancer","volume":"39","author":"H Chen","year":"2010","journal-title":"Pancreas"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline","volume":"99","author":"J W Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/BF01938677","article-title":"Ein Fall von doppelseitigem, v\u00f6llig latent verlaufenen Nebennierentumor und gleichzeitiger Nephritis mit Ver\u00e4nderungen am Circulationsapparat und Retinitis","volume":"103","author":"F Fr\u00e4nkel","year":"1886","journal-title":"Arch Pathol Anatom Physiol Klin Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1210\/js.2017-00208","article-title":"Max Schottelius: Pioneer in Pheochromocytoma","volume":"1","author":"B Bausch","year":"2017","journal-title":"J Endocr Soc"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1113\/jphysiol.1897.sp000660","article-title":"On the chromogen and on the active physiological substance of the suprarenal gland","volume":"21","author":"B Moore","year":"1897","journal-title":"J Physiol"},{"key":"ref6","first-page":"3","article-title":"On epinephrine, the active constituent of the suprarenal capsule and its compounds","volume":"2","author":"J J Abel","year":"1899","journal-title":"Am J Physiol"},{"key":"ref7","first-page":"523","article-title":"Adrenalin the active principle of the supra\u2013renal glands and its mode of preparation","volume":"73","author":"J Takamine","year":"1901","journal-title":"Am J Pharm"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1353.001","article-title":"An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges","volume":"1073","author":"W M Manger","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/jama.1927.02690130035013","article-title":"Paroxysmal hypertension with tumor of retroperitoneal nerve","volume":"89","author":"C Mayo","year":"1927","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199210013271417","article-title":"Laparoscopic adrenalectomy in Cushing\u2019s syndrome and pheochromocytoma","volume":"327","author":"M Gagner","year":"1992","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa071407","article-title":"Evidence of MEN-2 in the original description of classic pheochromocytoma","volume":"357","author":"H P Neumann","year":"2007","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2012.01.009","article-title":"Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background","volume":"205","author":"L Fishbein","year":"2012","journal-title":"Cancer Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1210\/jc.2009-1632","article-title":"Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas","volume":"95","author":"N van Duinen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.ejca.2011.07.016","article-title":"Plasma methoxytyramine: Anovel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status","volume":"48","author":"G Eisenhofer","year":"2012","journal-title":"Eur J Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/bja\/72.6.707","article-title":"Use of desflurane during resection of phaeochromocytoma","volume":"72","author":"M Lippmann","year":"1994","journal-title":"Br J Anaesth"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00000542-198202000-00003","article-title":"Histamine release during morphine and fentanyl anesthesia","volume":"56","author":"C E Rosow","year":"1982","journal-title":"Anesthesiology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00000542-197705000-00014","article-title":"The pressor effect of droperidol on a patient with pheochromocytoma","volume":"46","author":"K Sumikawa","year":"1977","journal-title":"Anesthesiology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1053\/j.jvca.2017.02.023","article-title":"Perioperative management of pheochromocytoma","volume":"31","author":"J Naranjo","year":"2017","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1210\/jc.2012-3669","article-title":"Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines?","volume":"98","author":"R F Stolk","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/heartjnl-2013-304073","article-title":"Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma","volume":"99","author":"A Giavarini","year":"2013","journal-title":"Heart"},{"key":"ref21","first-page":"16","article-title":"Bowel perforation complicating an ACTH-secreting phaeochromocytoma","author":"E Flynn","year":"2016","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12020-012-9646-7","article-title":"Mini-review: Pheochromocytomas causing the ectopic ACTH syndrome","volume":"42","author":"C Ballav","year":"2012","journal-title":"Endocrine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.4158\/EP11370.CR","article-title":"Pheochromocytoma with histologic transformation to composite type, complicated by watery diarrhea, hypokalemia, and achlorhydria syndrome","volume":"18","author":"Y Kikuchi","year":"2012","journal-title":"Endocr Pract"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: How to distinguish true- from false-positive test results","volume":"88","author":"G Eisenhofer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1002\/1097-0142(20000615)88:12<2811::AID-CNCR21>3.0.CO;2-7","article-title":"Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal","volume":"88","author":"J C Jansen","year":"2000","journal-title":"Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/archotol.124.10.1133","article-title":"Vagal paraganglioma: A review of 46 patients treated during a 20-year period","volume":"124","author":"J L Netterville","year":"1998","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0030-6665(05)70356-X","article-title":"Glomus tympanicum and glomus jugulare tumors","volume":"34","author":"C G Jackson","year":"2001","journal-title":"Otolaryngol Clin North Am"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejvs.2018.10.038","article-title":"A systematic review and meta-analysis of the presentation and surgical management of patients with carotid body tumours","volume":"57","author":"V Robertson","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0002-9610(96)00151-1","article-title":"Carotid body tumors, inheritance, and a high incidence of associated cervical paragangliomas","volume":"172","author":"P Gardner","year":"1996","journal-title":"Am J Surg"},{"key":"ref30","first-page":"460","article-title":"Incidentally discovered adrenal masses","volume":"16","author":"R T Kloos","year":"1995","journal-title":"Endocr Rev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0889-8529(05)70122-5","article-title":"Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota","volume":"29","author":"W F Young Jr","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12020-017-1300-y","article-title":"Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: A systematic review","volume":"56","author":"R Darr","year":"2017","journal-title":"Endocrine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/eci.12245","article-title":"Clinical utility of chromogranin A in SDHx-related paragangliomas","volume":"44","author":"S Zuber","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1373\/clinchem.2006.076489","article-title":"Is supine rest necessary before blood sampling for plasma metanephrines?","volume":"53","author":"J W Lenders","year":"2007","journal-title":"Clin Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2008-1093","article-title":"Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene","volume":"93","author":"H J Timmers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1373\/clinchem.2004.045484","article-title":"Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines","volume":"51","author":"G Eisenhofer","year":"2005","journal-title":"Clin Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/ERC-16-0231","article-title":"Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome","volume":"23","author":"R Darr","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.2967\/jnumed.116.187690","article-title":"Functional imaging signature of patients presenting with polycythemia\/paraganglioma syndromes","volume":"58","author":"I Janssen","year":"2017","journal-title":"J Nucl Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: Learning from genetic heterogeneity","volume":"14","author":"P L Dahia","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.surg.2016.05.059","article-title":"Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors","volume":"161","author":"B Babic","year":"2017","journal-title":"Surgery"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","author":"Group NGSiPS","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.surg.2017.05.025","article-title":"Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery","volume":"163","author":"P Nockel","year":"2018","journal-title":"Surgery"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/jc.2018-02411","article-title":"Positive impact of genetic test on the management and outcome of patients with paraganglioma and\/or pheochromocytoma","volume":"104","author":"A Buffet","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrendo.2014.188","article-title":"Paraganglioma and phaeochromocytoma: From genetics to personalized medicine","volume":"11","author":"J Favier","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/s41436-018-0003-y","article-title":"Gain-of-function mutations in DNMT3A in patients with paraganglioma","volume":"20","author":"L Remacha","year":"2018","journal-title":"Genet Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1158\/1078-0432.CCR-16-2250","article-title":"targeted exome sequencing of krebs cycle genes reveals candidate cancer-predisposing mutations in pheochromocytomas and paragangliomas","volume":"23","author":"L Remacha","year":"2017","journal-title":"Clin Cancer Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1158\/0008-5472.CAN-17-2463","article-title":"Germline Mutations in the Mitochondrial 2-Oxoglutarate\/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas","volume":"78","author":"A Buffet","year":"2018","journal-title":"Cancer Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"L Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/gcc.22267","article-title":"Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene","volume":"54","author":"C C Juhlin","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4158\/EP161718.RA","article-title":"Precision Medicine: An Update on Genotype\/Biochemical Phenotype Relationships in Pheochromocytoma\/Paraganglioma Patients","volume":"23","author":"G Gupta","year":"2017","journal-title":"Endocr Pract"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cen.12331","article-title":"Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas","volume":"80","author":"A M McInerney-Leo","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"E1248","DOI":"10.1210\/jc.2013-1319","article-title":"A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma","volume":"98","author":"E Rattenberry","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"L J Castro-Vega","year":"2014","journal-title":"Hum Mol Genet"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"E Letouze","year":"2013","journal-title":"Cancer Cell"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"djv053","DOI":"10.1093\/jnci\/djv053","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","volume":"107","author":"A Cascon","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"M A Selak","year":"2005","journal-title":"Cancer Cell"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1101\/gad.191056.112","article-title":"Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors","volume":"26","author":"M Xiao","year":"2012","journal-title":"Genes Dev"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"J A Forsythe","year":"1996","journal-title":"Mol Cell Biol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1073\/pnas.94.9.4273","article-title":"A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development","volume":"94","author":"M Ema","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1101\/gad.14.16.1983","article-title":"HIF-1 and human disease: One highly involved factor","volume":"14","author":"G L Semenza","year":"2000","journal-title":"Genes Dev"},{"key":"ref61","first-page":"5615","article-title":"Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas","volume":"63","author":"A P Gimenez-Roqueplo","year":"2003","journal-title":"Cancer Res"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2016-3829","article-title":"Characteristics of Pediatric vs. Adult Pheochromocytomas and Paragangliomas","volume":"102","author":"C Pamporaki","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.surg.2016.05.050","article-title":"SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma","volume":"161","author":"Y Assadipour","year":"2017","journal-title":"Surgery"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00432-017-2397-3","article-title":"SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations","volume":"143","author":"I Jochmanova","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/cen.13246","article-title":"Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers","volume":"86","author":"N Tufton","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/humu.21136","article-title":"Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD","volume":"31","author":"C J Ricketts","year":"2010","journal-title":"Hum Mutat"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1200\/JCO.2011.34.6353","article-title":"Metastatic pheochromocytoma\/paraganglioma related to primary tumor development in childhood or adolescence: Significant link to SDHB mutations","volume":"29","author":"K S King","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","article-title":"Genetic testing in pheochromocytoma or functional paraganglioma","volume":"23","author":"L Amar","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.surg.2007.09.013","article-title":"Pheochromocytoma penetrance varies by RET mutation in MEN 2A","volume":"142","author":"F J Quayle","year":"2007","journal-title":"Surgery"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1210\/me.2010-0256","article-title":"Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas","volume":"24","author":"E Lopez-Jimenez","year":"2010","journal-title":"Mol Endocrinol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","article-title":"Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma","volume":"20","author":"N Burnichon","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/hmg\/ddt069","article-title":"Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis","volume":"22","author":"I Comino-Mendez","year":"2013","journal-title":"Hum Mol Genet"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/jc.2006-2315","article-title":"Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas","volume":"92","author":"H J Timmers","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1210\/jc.2004-2025","article-title":"Biochemical and clinical manifestations of dopamine-producing paragangliomas: Utility of plasma methoxytyramine","volume":"90","author":"G Eisenhofer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1530\/EJE-15-0549","article-title":"Management of Endocriene Disease: Outcome of adrenal sparing surgery in heritable pheochromocytoma","volume":"174","author":"F Castinetti","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jcem.86.5.7496","article-title":"Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes","volume":"86","author":"G Eisenhofer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1677\/ERC-09-0024","article-title":"Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas","volume":"16","author":"B Havekes","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00006231-200607000-00006","article-title":"Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: A prospective study","volume":"27","author":"F Lumachi","year":"2006","journal-title":"Nucl Med Commun"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/110241598750004913","article-title":"Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: A review of 282 cases. French Association of Surgery (AFC), and The French Association of Endocrine Surgeons (AFCE)","volume":"164","author":"N D Jalil","year":"1998","journal-title":"Eur J Surg"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.1210\/jc.2012-2975","article-title":"Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: A multicenter prospective study from the PGL.EVA Investigators","volume":"98","author":"A P Gimenez-Roqueplo","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1007\/s00330-008-1073-z","article-title":"Adrenal phaeochromocytoma: Correlation of MRI appearances with histology and function","volume":"18","author":"A E Jacques","year":"2008","journal-title":"Eur Radiol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12020-015-0544-7","article-title":"The incremental benefit of functional imaging in pheochromocytoma\/paraganglioma: A systematic review","volume":"50","author":"J P Brito","year":"2015","journal-title":"Endocrine"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","article-title":"Superiority of [68Ga]-DOTATATE PET\/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma","volume":"21","author":"I Janssen","year":"2015","journal-title":"Clin Cancer Res"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1210\/jc.2009-1248","article-title":"Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma","volume":"94","author":"H J Timmers","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0033","article-title":"European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma","volume":"174","author":"P F Plouin","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2967\/jnumed.115.161018","article-title":"68Ga-DOTATATE PET\/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT\/MRI","volume":"57","author":"I Janssen","year":"2016","journal-title":"J Nucl Med"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s00259-016-3357-x","article-title":"PET\/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT\/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma","volume":"43","author":"I Janssen","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/er.2017-00062","article-title":"New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification","volume":"38","author":"J Crona","year":"2017","journal-title":"Endocr Rev"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/cen.13066","article-title":"Are patients with hormonally functional phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort study","volume":"85","author":"H V Luiz","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1097\/HJH.0b013e32834d24d9","article-title":"Preoperative alpha blockade for normotensive pheochromocytoma: is it necessary?","volume":"29","author":"Y Shao","year":"2011","journal-title":"J Hypertens"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0022-5347(01)61762-2","article-title":"Successful outcomes in pheochromocytoma surgery in the modern era","volume":"161","author":"J C Ulchaker","year":"1999","journal-title":"J Urol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2002.tb04408.x","article-title":"Pheochromocytoma: an approach to antihypertensive management","volume":"970","author":"E L Bravo","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/bja\/aew392","article-title":"Perioperative alpha-receptor blockade in phaeochromocytoma surgery: An observational case series","volume":"118","author":"H Groeben","year":"2017","journal-title":"Br J Anaesth"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1210\/jc.2007-1720","article-title":"Preoperative management of the pheochromocytoma patient","volume":"92","author":"K Pacak","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2012-3020","article-title":"Pheochromocytoma crisis is not a surgical emergency","volume":"98","author":"A Scholten","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.5603\/KP.a2017.0147","article-title":"Comparison of phenoxybenzamine and doxazosin in perioperative management of patients with pheochromocytoma","volume":"75","author":"K Malec","year":"2017","journal-title":"Kardiol Pol"},{"key":"ref97","volume-title":"Goodman & Gilman\u2019s The pharmacological basis of therapeutics","author":"LSB L Goodman","year":"2018"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1053\/j.jvca.2012.01.002","article-title":"Perioperative management of pheochromocytoma: Focus on magnesium, clevidipine, and vasopressin","volume":"26","author":"M S Lord","year":"2012","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s00268-007-9327-5","article-title":"Safety of laparoscopic adrenalectomy in patients with large pheochromocytomas: A single institution review","volume":"32","author":"G Ippolito","year":"2008","journal-title":"World J Surg"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.surg.2006.07.008","article-title":"Analysis of large versus small pheochromocytomas: Operative approaches and patient outcomes","volume":"140","author":"S M Wilhelm","year":"2006","journal-title":"Surgery"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0039-6060(97)90218-X","article-title":"Laparoscopic versus open posterior adrenalectomy: A case-control study of 100 patients","volume":"122","author":"G B Thompson","year":"1997","journal-title":"Surgery"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00464-012-2451-9","article-title":"Outcomes of resection of extra-adrenal pheochromocytomas\/paragangliomas in the laparoscopic era: A comparison with adrenal pheochromocytoma","volume":"27","author":"T A Goers","year":"2013","journal-title":"Surg Endosc"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00423-011-0851-2","article-title":"Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas","volume":"397","author":"P F Alesina","year":"2012","journal-title":"Langenbecks Arch Surg"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1210\/jc.2015-3045","article-title":"Pheochromocytoma Screening initiation and frequency in von Hippel\u2013Lindau syndrome","volume":"100","author":"R D Aufforth","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S1470-2045(14)70154-8","article-title":"Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: An international retrospective population-based study","volume":"15","author":"F Castinetti","year":"2014","journal-title":"Lancet Oncol"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1210\/jc.2005-0064","article-title":"Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2","volume":"90","author":"A Machens","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"E1813","DOI":"10.1210\/jc.2013-1653","article-title":"The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2","volume":"98","author":"S Thosani","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.jpedsurg.2012.07.003","article-title":"Partial adrenalectomy minimizes the need for long-term hormone replacement in pediatric patients with pheochromocytoma and von Hippel\u2013Lindau syndrome","volume":"47","author":"D Volkin","year":"2012","journal-title":"J Pediatr Surg"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.juro.2010.06.102","article-title":"Functional and oncologic outcomes of partial adrenalectomy for pheochromocytoma in patients with von Hippel\u2013Lindau syndrome after at least 5 years of followup","volume":"184","author":"J N Benhammou","year":"2010","journal-title":"J Urol"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/archsurg.141.12.1199","article-title":"Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A","volume":"141","author":"R Asari","year":"2006","journal-title":"Arch Surg"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s13304-017-0448-6","article-title":"Robot-assisted adrenalectomy: Indications and drawbacks","volume":"69","author":"C Nomine-Criqui","year":"2017","journal-title":"Updates Surg"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/iju.13241","article-title":"Laparoscopic transperitoneal adrenalectomy in morbidly obese patients is not associated with worse short-term outcomes","volume":"24","author":"M Pedziwiatr","year":"2017","journal-title":"Int J Urol"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.surg.2017.05.029","article-title":"Hemodynamic instability during surgery for pheochromocytoma: Comparing the transperitoneal and retroperitoneal approach in a multicenter analysis of 341 patients","volume":"163","author":"W Vorselaars","year":"2018","journal-title":"Surgery"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00464-015-4294-7","article-title":"Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma: A multicenter retrospective analysis in 225 patients","volume":"30","author":"L Brunaud","year":"2016","journal-title":"Surg Endosc"},{"key":"ref115","first-page":"213","volume-title":"Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours","author":"A K Lam","year":"2017"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/SLA.0000000000002195","article-title":"Impact of surgical resection of the primary tumor on overall survival in patients with metastatic pheochromocytoma or sympathetic paraganglioma","volume":"268","author":"A Roman-Gonzalez","year":"2018","journal-title":"Ann Surg"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jamcollsurg.2013.04.027","article-title":"Response after surgical resection of metastatic pheochromocytoma and paraganglioma: Can postoperative biochemical remission be predicted?","volume":"217","author":"R J Ellis","year":"2013","journal-title":"J Am Coll Surg"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1677\/erc.1.00829","article-title":"Malignant pheochromocytoma: Current status and initiatives for future progress","volume":"11","author":"G Eisenhofer","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11912-013-0320-x","article-title":"Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma","volume":"15","author":"C Jimenez","year":"2013","journal-title":"Curr Oncol Rep"},{"key":"ref120","first-page":"196","article-title":"Laparoscopic surgery for malignant adrenal tumors","volume":"13","author":"G N Zografos","year":"2009","journal-title":"JSLS"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jamasurg.2018.3475","article-title":"Radioguided surgery with gallium 68 dotatate for patients with neuroendocrine tumors","volume":"154","author":"M El Lakis","year":"2019","journal-title":"JAMA Surg"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/SLA.0000000000000283","article-title":"The presence of SDHB mutations should modify surgical indications for carotid body paragangliomas","volume":"260","author":"R J Ellis","year":"2014","journal-title":"Ann Surg"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.radonc.2012.11.002","article-title":"Regression and local control rates after radiotherapy for jugulotympanic paragangliomas: Systematic review and meta-analysis","volume":"106","author":"L T van Hulsteijn","year":"2013","journal-title":"Radiother Oncol"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/0002-9610(71)90436-3","article-title":"Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases","volume":"122","author":"W R Shamblin","year":"1971","journal-title":"Am J Surg"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1007\/s00268-015-3058-9","article-title":"preoperative imaging features are associated with surgical complications following carotid body tumor resection","volume":"39","author":"D M Straughan","year":"2015","journal-title":"World J Surg"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00423-015-1277-z","article-title":"Surgical therapy of neuroendocrine neoplasm with hepatic metastasis: Patient selection and prognosis","volume":"400","author":"F M Watzka","year":"2015","journal-title":"Langenbecks Arch Surg"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11020195","volume-title":"efficacy and safety of ablative therapy in the treatment of patients with metastatic pheochromocytoma and paraganglioma","author":"J Kohlenberg","year":"2019"},{"key":"ref128","first-page":"54","article-title":"Occurrence of phaeochromocytoma tumours in RET mutation carriers - A single-centre study","volume":"67","author":"A Kotecka-Blicharz","year":"2016","journal-title":"Endokrynol Pol"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1210\/jc.2008-2419","article-title":"Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and\/or functional or nonfunctional paragangliomas","volume":"94","author":"M Mannelli","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.292.8.943","article-title":"Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations","volume":"292","author":"H P Neumann","year":"2004","journal-title":"JAMA"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2008-2504","article-title":"The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas","volume":"94","author":"N Burnichon","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2005-1862","article-title":"Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes","volume":"91","author":"D E Benn","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1210\/jc.2017-01762","article-title":"Clinical Aspects of SDHA-Related Pheochromocytoma and Paraganglioma: A Nationwide Study","volume":"103","author":"K van der Tuin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jamaoncol.2017.0223","article-title":"Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention","volume":"3","author":"B Bausch","year":"2017","journal-title":"JAMA Oncol"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/modpathol.2015.41","article-title":"SDHB\/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: A multicenter interobserver variation analysis using virtual microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)","volume":"28","author":"T G Papathomas","year":"2015","journal-title":"Mod Pathol"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"L43","DOI":"10.1530\/ERC-17-0030","article-title":"SDHA mutated paragangliomas may be at high risk of metastasis","volume":"24","author":"N Tufton","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"E1482","DOI":"10.1210\/jc.2013-3853","article-title":"The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3)","volume":"99","author":"T Else","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1210\/jc.2016-1665","article-title":"A SDHC Founder Mutation Causes Paragangliomas (PGLs) in the French Canadians: New Insights on the SDHC-Related PGL","volume":"101","author":"I Bourdeau","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"ref139","doi-asserted-by":"crossref","first-page":"E1392","DOI":"10.1210\/jc.2013-4536","article-title":"Universal genetic screening uncovers a novel presentation of an SDHAF2 mutation","volume":"99","author":"R Casey","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1158\/1078-0432.CCR-10-0420","article-title":"SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma","volume":"17","author":"H P Kunst","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1530\/EJE-16-0233","article-title":"Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1","volume":"175","author":"L Kepenekian","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/cen.13265","article-title":"Pheochromocytomas are diagnosed incidentally and at older age in neurofibromatosis type 1","volume":"86","author":"J Moramarco","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/cen.13163","article-title":"Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1","volume":"86","author":"L M Gruber","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0022-5347(05)68171-2","article-title":"von Recklinghausen\u2019s disease and pheochromocytomas","volume":"162","author":"M M Walther","year":"1999","journal-title":"J Urol"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/ERC-13-0384","article-title":"Frequent EPAS1\/HIF2alpha exons 9 and 12 mutations in non-familial pheochromocytoma","volume":"21","author":"J Welander","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"ref146","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma","volume":"18","author":"N Burnichon","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref147","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1001\/jama.2010.1830","article-title":"Spectrum and prevalence of FP\/TMEM127 gene mutations in pheochromocytomas and paragangliomas","volume":"304","author":"L Yao","year":"2010","journal-title":"JAMA"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/gcc.22347","article-title":"HRAS mutation prevalence and associated expression patterns in pheochromocytoma","volume":"55","author":"A Stenman","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"ref149","doi-asserted-by":"crossref","first-page":"E1376","DOI":"10.1210\/jc.2013-3879","article-title":"H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: Data from a multi-institutional series","volume":"99","author":"L Oudijk","year":"2014","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Hormone and Metabolic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-0926-3618.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T03:24:12Z","timestamp":1645759452000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-0926-3618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":149,"journal-issue":{"issue":"07","published-online":{"date-parts":[[2019,7,15]]},"published-print":{"date-parts":[[2019,7]]}},"URL":"https:\/\/doi.org\/10.1055\/a-0926-3618","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0018-5043","1439-4286"],"issn-type":[{"value":"0018-5043","type":"print"},{"value":"1439-4286","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}